Literature DB >> 8183761

Prolonged remission of hypercalcaemia due to parathyroid carcinoma with pamidronate.

P G Newrick1, G D Braatvedt, A J Webb, E Sheffield, R J Corrall.   

Abstract

Parathyroid carcinoma is rare and the associated hypercalcaemia is often resistant to all treatment. A case is described in which prolonged control of hypercalcaemia has been achieved by infrequent infusions of pamidronate despite continuing hypersecretion of parathyroid hormone.

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 8183761      PMCID： PMC2397857          DOI： 10.1136/pgmj.70.821.231

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN： 0032-5473            Impact factor:   2.401


  4 in total

1.  Disodium clodronate effective in management of severe hypercalcaemia caused by parathyroid carcinoma.

Authors:  D Jüngst
Journal:  Lancet       Date:  1984-11-03       Impact factor: 79.321

2.  Oral biphosphonate therapy in metastatic parathyroid carcinoma.

Authors:  K Mann
Journal:  Lancet       Date:  1985-01-12       Impact factor: 79.321

3.  Aminopropylidine diphosphonate (APD) in mild primary hyperparathyroidism: effect on clinical status.

Authors:  R S Schmidli; I Wilson; E A Espiner; A M Richards; R A Donald
Journal:  Clin Endocrinol (Oxf)       Date:  1990-03       Impact factor: 3.478

4.  Parathyroid carcinoma: the Lahey Clinic experience.

Authors:  K Cohn; M Silverman; J Corrado; C Sedgewick
Journal:  Surgery       Date:  1985-12       Impact factor: 3.982
  4 in total
  5 in total

1.  Denosumab for management of parathyroid carcinoma-mediated hypercalcemia.

Authors:  Priyathama Vellanki; Karoline Lange; Dina Elaraj; Peter A Kopp; Malek El Muayed
Journal:  J Clin Endocrinol Metab       Date:  2013-10-31       Impact factor: 5.958

2.  Severe Hyperparathyroidism Versus Parathyroid Carcinoma: A clinical dilemma.

Authors:  Mariam Al-Fadhli; Suhail A R Doi; Thomas Muttikkal; Basel Al-Sumait
Journal:  Sultan Qaboos Univ Med J       Date:  2010-04-17

3.  Cinacalcet hydrochloride relieves hypercalcemia in Japanese patients with parathyroid cancer and intractable primary hyperparathyroidism.

Authors:  Yasuhiro Takeuchi; Shunsuke Takahashi; Daishu Miura; Makoto Katagiri; Noriaki Nakashima; Hiroko Ohishi; Ryutaro Shimazaki; Yoshihiro Tominaga
Journal:  J Bone Miner Metab       Date:  2016-11-21       Impact factor: 2.626

4.  Mortality factors in recurrent parathyroid cancer: a pooled analysis.

Authors:  Wen-Hsuan Tsai; Yi-Hong Zeng; Chun-Chuan Lee; Ming-Chieh Tsai
Journal:  J Bone Miner Metab       Date:  2022-02-20       Impact factor: 2.626

Review 5.  Parathyroid carcinoma: etiology, diagnosis, and treatment.

Authors:  Takahiro Okamoto; Masatoshi Iihara; Takao Obara; Toshihiko Tsukada
Journal:  World J Surg       Date:  2009-11       Impact factor: 3.352
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.